title: Long-term efficacy and safety of otilonium bromide in the management of irritable bowel syndrome: a literature review.
abstract: Irritable bowel syndrome (IBS) is a very common functional gastrointestinal disorder characterized by abdominal pain or discomfort and altered bowel habits. The disease affects a large part of the world population. The clinical course is mostly characterized by a cyclic recurrence of symptoms. Therefore, IBS patients should receive, as an initial therapeutic approach, a short course of treatment, and long-term treatment should be reserved for those patients with recurrent symptoms. The available clinical trials show that significant improvement of the symptoms over placebo could be achieved with various drugs, although this improvement is frequently time dependent and with high relapse rates after the cessation of the treatment. In a proportion of patients, clinically obvious relapse could appear long after stopping the treatment. Some of the available pharmacologic agents, including otilonium bromide (OB), are able to significantly prolong the time to the appearance of relapse, compared with placebo. As a consequence, some authors suggest that a cyclic treatment could be of benefit. Antispasmodic drugs have been used for many years in an effort to control the symptoms of IBS. OB is a poorly absorbed spasmolytic drug, exerting significantly greater control of the symptoms of IBS compared with placebo. Recent data suggest that the drug could effectively be used for the long-term management of patients with IBS. The aim of this review is to provide the reader with an evidence-based overview of the efficacy and tolerability of OB in the long-term management of IBS patients, based on the results of the clinical trials published so far.
authors.affiliation: Inflammatory Bowel Disease Unit, IASO General Hospital, Athens, Greece.
authors.forename: John K
authors.initials: JK
authors.lastname: Triantafillidis
authors.affiliation: Inflammatory Bowel Disease Unit, IASO General Hospital, Athens, Greece.
authors.forename: George
authors.initials: G
authors.lastname: Malgarinos
keywords: IBS; irritable bowel syndrome; otilonium bromide; treatment
references.citation: Neurogastroenterol Motil. 2013 Dec;25(12):e803-12
references.pmid: 23941257
references.citation: Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1155-71
references.pmid: 23047498
references.citation: J Neurogastroenterol Motil. 2011 Oct;17(4):402-10
references.pmid: 22148110
references.citation: Aliment Pharmacol Ther. 2004 Dec;20(11-12):1253-69
references.pmid: 15606387
references.citation: Clin Drug Investig. 2007;27(1):15-33
references.pmid: 17177577
references.citation: Eur J Clin Pharmacol. 1997;52(5):365-9
references.pmid: 9272405
references.citation: Curr Opin Gastroenterol. 2011 Jan;27(1):72-8
references.pmid: 21099429
references.citation: Clin Ter. 1992 Aug;141(8):129-34
references.pmid: 1395455
references.citation: Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):60-3
references.pmid: 1756285
references.citation: Am J Gastroenterol. 2005 May;100(5):1174-84
references.pmid: 15842596
references.citation: Gastroenterol Clin Biol. 2009 Feb;33 Suppl 1:S84-90
references.pmid: 19303543
references.citation: Br J Pharmacol. 2002 Dec;137(7):1134-42
references.pmid: 12429587
references.citation: Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):64-6
references.pmid: 1756286
references.citation: Arch Pharm Res. 2008 Jan;31(1):117-24
references.pmid: 18277617
references.citation: Aliment Pharmacol Ther. 2006 Mar 15;23(6):815-26
references.pmid: 16556184
references.citation: Dig Dis Sci. 1986 Mar;31(3):241-6
references.pmid: 3948628
references.citation: Dig Dis Sci. 1998 Dec;43(12):2715-8
references.pmid: 9881504
references.citation: Neurogastroenterol Motil. 2004 Apr;16(2):175-83
references.pmid: 15086871
references.citation: Drug Metab Dispos. 2000 Jun;28(6):643-7
references.pmid: 10820135
references.citation: Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):67-70
references.pmid: 1661630
references.citation: Arch Int Pharmacodyn Ther. 1991 May-Jun;311:5-19
references.pmid: 1724144
references.citation: J Pharm Sci. 2008 Sep;97(9):4087-100
references.pmid: 18200532
references.citation: Pharmacol Res. 1998 Aug;38(2):111-7
references.pmid: 9721598
references.citation: Ann Intern Med. 1995 Jan 15;122(2):107-12
references.pmid: 7992984
references.citation: Neurogastroenterol Motil. 2011 Jan;23(1):96-102, e10
references.pmid: 20879991
references.citation: Neurogastroenterol Motil. 2013 Nov;25(11):e728-39
references.pmid: 23901937
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1999 May;359(5):420-7
references.pmid: 10498293
references.citation: J Physiol Paris. 2001 Jan-Dec;95(1-6):153-6
references.pmid: 11595430
references.citation: J Intern Med. 1994 Jul;236(1):23-30
references.pmid: 8021568
references.citation: Eur J Gastroenterol Hepatol. 2002 Dec;14(12):1331-8
references.pmid: 12468954
references.citation: Gastroenterol Res Pract. 2012;2012:936960
references.pmid: 22272195
references.citation: Aliment Pharmacol Ther. 1998 Oct;12(10):1003-10
references.pmid: 9798806
references.citation: Neurogastroenterol Motil. 2004 Apr;16(2):167-73
references.pmid: 15086870
references.citation: Aliment Pharmacol Ther. 2006 Jul 15;24(2):207-36
references.pmid: 16842449
references.citation: Int J Colorectal Dis. 2013 Mar;28(3):295-304
references.pmid: 23178991
references.citation: Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G706-13
references.pmid: 20203058
references.citation: Neurogastroenterol Motil. 2010 Jun;22(6):e180-91
references.pmid: 20367799
references.citation: Am J Epidemiol. 1992 Jul 15;136(2):165-77
references.pmid: 1415139
references.citation: Am J Gastroenterol. 2004 Jan;99(1):113-21
references.pmid: 14687152
references.citation: Curr Pharm Des. 2004;10(28):3561-8
references.pmid: 15579053
references.citation: Aliment Pharmacol Ther. 2004 Apr 15;19(8):861-70
references.pmid: 15080847
references.citation: Eur Rev Med Pharmacol Sci. 2012 Jan;16(1):25-37
references.pmid: 22338545
references.citation: Aliment Pharmacol Ther. 2011 Aug;34(4):432-42
references.pmid: 21679214